INVESCO LTD (IVZ) Stock Fundamental Analysis
USA - NYSE:IVZ - BMG491BT1088 - Common Stock
23.335 USD
-0.24 (-1.04%)
We assign a fundamental rating of 4 out of 10 to IVZ. IVZ was compared to 237 industry peers in the Capital Markets industry. IVZ has a bad profitability rating. Also its financial health evaluation is rather negative. IVZ is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
IVZ had positive earnings in the past year.
IVZ had a positive operating cash flow in the past year.
Of the past 5 years IVZ 4 years were profitable.
In the past 5 years IVZ always reported a positive cash flow from operatings.
1.2 Ratios
IVZ's Return On Assets of 2.35% is in line compared to the rest of the industry. IVZ outperforms 44.73% of its industry peers.
IVZ has a worse Return On Equity (4.77%) than 62.03% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.35% | ||
| ROE | 4.77% | ||
| ROIC | N/A |
ROA(3y)1.05%
ROA(5y)1.77%
ROE(3y)1.97%
ROE(5y)3.71%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
IVZ has a Profit Margin (10.64%) which is comparable to the rest of the industry.
IVZ's Profit Margin has been stable in the last couple of years.
IVZ has a worse Operating Margin (17.11%) than 61.18% of its industry peers.
In the last couple of years the Operating Margin of IVZ has declined.
The Gross Margin of IVZ (66.64%) is better than 75.11% of its industry peers.
IVZ's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.11% | ||
| PM (TTM) | 10.64% | ||
| GM | 66.64% |
OM growth 3Y-18.12%
OM growth 5Y-10.75%
PM growth 3Y-24%
PM growth 5Y-0.8%
GM growth 3Y-1.08%
GM growth 5Y-0.72%
2. Health
2.1 Basic Checks
Compared to 1 year ago, IVZ has less shares outstanding
Compared to 5 years ago, IVZ has less shares outstanding
Compared to 1 year ago, IVZ has an improved debt to assets ratio.
2.2 Solvency
The Debt to FCF ratio of IVZ is 7.13, which is on the high side as it means it would take IVZ, 7.13 years of fcf income to pay off all of its debts.
IVZ's Debt to FCF ratio of 7.13 is fine compared to the rest of the industry. IVZ outperforms 62.45% of its industry peers.
A Debt/Equity ratio of 0.71 indicates that IVZ is somewhat dependend on debt financing.
IVZ has a Debt to Equity ratio (0.71) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 7.13 | ||
| Altman-Z | N/A |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
A Current Ratio of 0.75 indicates that IVZ may have some problems paying its short term obligations.
With a Current ratio value of 0.75, IVZ is not doing good in the industry: 68.35% of the companies in the same industry are doing better.
A Quick Ratio of 0.75 indicates that IVZ may have some problems paying its short term obligations.
IVZ has a worse Quick ratio (0.75) than 67.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.75 | ||
| Quick Ratio | 0.75 |
3. Growth
3.1 Past
IVZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.57%, which is quite good.
Measured over the past years, IVZ shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.57% on average per year.
Looking at the last year, IVZ shows a small growth in Revenue. The Revenue has grown by 6.63% in the last year.
Measured over the past years, IVZ shows a decrease in Revenue. The Revenue has been decreasing by -0.17% on average per year.
EPS 1Y (TTM)15.57%
EPS 3Y-17.74%
EPS 5Y-7.57%
EPS Q2Q%38.64%
Revenue 1Y (TTM)6.63%
Revenue growth 3Y-4.17%
Revenue growth 5Y-0.17%
Sales Q2Q%7.43%
3.2 Future
Based on estimates for the next years, IVZ will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.33% on average per year.
IVZ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.02% yearly.
EPS Next Y14.83%
EPS Next 2Y21.53%
EPS Next 3Y18.86%
EPS Next 5Y9.33%
Revenue Next Year5.14%
Revenue Next 2Y8.14%
Revenue Next 3Y7.02%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 12.09, which indicates a correct valuation of IVZ.
Compared to the rest of the industry, the Price/Earnings ratio of IVZ indicates a somewhat cheap valuation: IVZ is cheaper than 60.34% of the companies listed in the same industry.
IVZ's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.51.
IVZ is valuated reasonably with a Price/Forward Earnings ratio of 9.19.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IVZ indicates a somewhat cheap valuation: IVZ is cheaper than 74.26% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.53, IVZ is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.09 | ||
| Fwd PE | 9.19 |
4.2 Price Multiples
IVZ's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. IVZ is cheaper than 76.79% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IVZ indicates a somewhat cheap valuation: IVZ is cheaper than 78.06% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.47 | ||
| EV/EBITDA | 16.31 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as IVZ's earnings are expected to grow with 18.86% in the coming years.
PEG (NY)0.82
PEG (5Y)N/A
EPS Next 2Y21.53%
EPS Next 3Y18.86%
5. Dividend
5.1 Amount
IVZ has a Yearly Dividend Yield of 3.54%.
Compared to an average industry Dividend Yield of 8.38, IVZ has a dividend in line with its industry peers.
IVZ's Dividend Yield is a higher than the S&P500 average which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.54% |
5.2 History
The dividend of IVZ decreases each year by -2.49%.
IVZ has been paying a dividend for at least 10 years, so it has a reliable track record.
IVZ has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-2.49%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
22.75% of the earnings are spent on dividend by IVZ. This is a low number and sustainable payout ratio.
DP22.75%
EPS Next 2Y21.53%
EPS Next 3Y18.86%
NYSE:IVZ (11/4/2025, 3:18:09 PM)
23.335
-0.24 (-1.04%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners94.95%
Inst Owner Change-0.37%
Ins Owners0.69%
Ins Owner Change0.54%
Market Cap10.41B
Revenue(TTM)6.28B
Net Income(TTM)668.00M
Analysts69.47
Price Target25.85 (10.78%)
Short Float %3.81%
Short Ratio3.08
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.54% |
Yearly Dividend1.35
Dividend Growth(5Y)-2.49%
DP22.75%
Div Incr Years3
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)10.27%
Min EPS beat(2)-12.91%
Max EPS beat(2)33.45%
EPS beat(4)3
Avg EPS beat(4)10.77%
Min EPS beat(4)-12.91%
Max EPS beat(4)33.45%
EPS beat(8)6
Avg EPS beat(8)6.33%
EPS beat(12)8
Avg EPS beat(12)2.97%
EPS beat(16)9
Avg EPS beat(16)-0.41%
Revenue beat(2)1
Avg Revenue beat(2)-0.02%
Min Revenue beat(2)-0.67%
Max Revenue beat(2)0.62%
Revenue beat(4)1
Avg Revenue beat(4)-0.34%
Min Revenue beat(4)-0.92%
Max Revenue beat(4)0.62%
Revenue beat(8)1
Avg Revenue beat(8)-1.91%
Revenue beat(12)3
Avg Revenue beat(12)3.37%
Revenue beat(16)7
Avg Revenue beat(16)9.27%
PT rev (1m)9.34%
PT rev (3m)46.93%
EPS NQ rev (1m)-1.2%
EPS NQ rev (3m)-2.94%
EPS NY rev (1m)1.76%
EPS NY rev (3m)4.01%
Revenue NQ rev (1m)1.03%
Revenue NQ rev (3m)2.43%
Revenue NY rev (1m)0.34%
Revenue NY rev (3m)1.48%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.09 | ||
| Fwd PE | 9.19 | ||
| P/S | 1.66 | ||
| P/FCF | 7.47 | ||
| P/OCF | 7.5 | ||
| P/B | 0.74 | ||
| P/tB | N/A | ||
| EV/EBITDA | 16.31 |
EPS(TTM)1.93
EY8.27%
EPS(NY)2.54
Fwd EY10.89%
FCF(TTM)3.13
FCFY13.4%
OCF(TTM)3.11
OCFY13.33%
SpS14.08
BVpS31.41
TBVpS-0.41
PEG (NY)0.82
PEG (5Y)N/A
Graham Number36.93
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.35% | ||
| ROE | 4.77% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 17.11% | ||
| PM (TTM) | 10.64% | ||
| GM | 66.64% | ||
| FCFM | 22.21% |
ROA(3y)1.05%
ROA(5y)1.77%
ROE(3y)1.97%
ROE(5y)3.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.86%
ROCE(5y)4.54%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-18.12%
OM growth 5Y-10.75%
PM growth 3Y-24%
PM growth 5Y-0.8%
GM growth 3Y-1.08%
GM growth 5Y-0.72%
F-Score5
Asset Turnover0.22
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 7.13 | ||
| Debt/EBITDA | 7.93 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 110.61% | ||
| Profit Quality | 208.68% | ||
| Current Ratio | 0.75 | ||
| Quick Ratio | 0.75 | ||
| Altman-Z | N/A |
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)75.57%
Cap/Depr(5y)67.25%
Cap/Sales(3y)2.4%
Cap/Sales(5y)2.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.57%
EPS 3Y-17.74%
EPS 5Y-7.57%
EPS Q2Q%38.64%
EPS Next Y14.83%
EPS Next 2Y21.53%
EPS Next 3Y18.86%
EPS Next 5Y9.33%
Revenue 1Y (TTM)6.63%
Revenue growth 3Y-4.17%
Revenue growth 5Y-0.17%
Sales Q2Q%7.43%
Revenue Next Year5.14%
Revenue Next 2Y8.14%
Revenue Next 3Y7.02%
Revenue Next 5YN/A
EBIT growth 1Y54.76%
EBIT growth 3Y-21.54%
EBIT growth 5Y-10.89%
EBIT Next Year16.45%
EBIT Next 3Y13.36%
EBIT Next 5Y7.53%
FCF growth 1Y63.44%
FCF growth 3Y4.97%
FCF growth 5Y2.62%
OCF growth 1Y32.1%
OCF growth 3Y3.35%
OCF growth 5Y1.42%
INVESCO LTD / IVZ FAQ
What is the fundamental rating for IVZ stock?
ChartMill assigns a fundamental rating of 4 / 10 to IVZ.
What is the valuation status for IVZ stock?
ChartMill assigns a valuation rating of 6 / 10 to INVESCO LTD (IVZ). This can be considered as Fairly Valued.
What is the profitability of IVZ stock?
INVESCO LTD (IVZ) has a profitability rating of 3 / 10.
What are the PE and PB ratios of INVESCO LTD (IVZ) stock?
The Price/Earnings (PE) ratio for INVESCO LTD (IVZ) is 12.09 and the Price/Book (PB) ratio is 0.74.
How sustainable is the dividend of INVESCO LTD (IVZ) stock?
The dividend rating of INVESCO LTD (IVZ) is 5 / 10 and the dividend payout ratio is 22.75%.